Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) announced it has entered into a non-binding letter of intent (LOI) to acquire Vancouver-based Quantum.IQ, an AI-driven quantum cybersecurity company. The acquisition is designed to help organizations prepare for emerging quantum-enabled cyber threats. Quantum.IQ’s post-quantum cryptography platform assists government, defense, financial services and critical infrastructure organizations in assessing cryptographic vulnerabilities, planning migration to quantum-resistant security systems and monitoring ongoing cybersecurity readiness.
Under the proposed transaction, Redwood would acquire all outstanding shares of Quantum.IQ in exchange for up to 14 million Redwood common shares, including milestone-based consideration. All shares are subject to a staged escrow release schedule over 24 months. The acquisition remains subject to due diligence, definitive agreements, regulatory approvals and other customary closing conditions. Redwood said the addition of Quantum.IQ could expand its capabilities in cryptographic intelligence, quantum-readiness assessment and cybersecurity planning, complementing its broader focus on artificial intelligence and advanced computational technologies.
This announcement comes at a critical time as quantum computing advances, threatening to break current encryption standards. Organizations worldwide are racing to adopt quantum-safe cryptography to protect sensitive data. By integrating Quantum.IQ’s platform, Redwood AI aims to offer a comprehensive suite of AI-driven solutions for chemistry R&D and now cybersecurity, potentially strengthening its position in the defense and critical infrastructure sectors. The deal highlights the growing convergence of AI and quantum technologies to address next-generation security challenges.
For more information on the LOI, visit https://ibn.fm/D0lb6. Additional details about Redwood AI can be found at https://redwoodai.com/.
Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.
